menu
    • menu
    [{"orgOrder":0,"company":"Revium Rx","sponsor":"WuXi AppTec","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"ISRAEL","productType":"Antibiotic","year":"2025","type":"Inapplicable","leadProduct":"Nano-Mupirocin","moa":"Bacterial isoleucyl-tRNA synthetase","graph1":"Infections and Infectious Diseases","graph2":"IND Enabling","graph3":"Revium Rx","amount2":0,"highestDevelopmentShortName":"IND","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Revium Rx \/ WuXi AppTec","highestDevelopmentStatusID":"5","companyTruncated":"Revium Rx \/ WuXi AppTec"}]

    Find Clinical Drug Pipeline Developments & Deals by Revium Rx

    Menu

    Revium Rx

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Revium Rx

                            Israel arrow
                            COMPAMED
                            Not Confirmed

                            Revium Rx

                            Israel arrow
                            COMPAMED
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Nano-Mupirocin

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : IND Enabling

                            Sponsor : WuXi AppTec

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Revium Rx Progresses to Phase 1 for Nano-Mupirocin Against Antibiotic-Resistant Infections

                            Details : Nano-Mupirocin, an antibiotic targeting bacterial isoleucyl-tRNA synthetase, shows promise in treating Methicillin-Resistant Staphylococcus aureus (MRSA).

                            Product Name : Undisclosed

                            Product Type : Antibiotic

                            Upfront Cash : Inapplicable

                            October 21, 2025

                            Lead Product(s) : Nano-Mupirocin

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : IND Enabling

                            Sponsor : WuXi AppTec

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth